4 ms·
Not sure about in the sciences, but large companies and their funders still do. e.g., 23AndMe, which still wants to become profitable through drug development b
by dundarious 3y ago
Not sure about in the sciences, but large companies and their funders still do. e.g., 23AndMe, which still wants to become profitable through drug development based pretty much only on DNA sequencing data.
I agree with the article, it's a paradigm that peaked 20 years ago, and has been outdated for about a decade.